PT-141 (Bremelanotide)

Compounded · Sexual Health Track

What it is

PT-141, also called bremelanotide — a melanocortin-receptor agonist that drives sexual desire from the central nervous system rather than the vascular side. Different mechanism from the PDE-5 inhibitor class. Works on the wanting, not the function. Compounded for us at a U.S. 503A-licensed pharmacy.

Who this protocol is for

Men and women whose libido has flattened despite normal hormone panels, patients who don’t tolerate or don’t want to rely on PDE-5 inhibitors, and patients whose sexual concerns are desire-side rather than vascular. Used by both sexes — PT-141 is one of the few sexual-health peptides with usable data across the gender spectrum.

How the Track works

Subcutaneous injection a few hours before intended use. Not a daily — used as needed. Your $149 covers the full year of telehealth — visits, dose guidance, refills. No per-script fees. Your medical director walks you through timing on your first protocol — PT-141 has a tolerance curve and a learning week.

Most patients tell us PT-141 surprised them — they expected something mechanical and got something more like an old appetite returning. The dose-response varies. Most find their window within the first three uses.

Stay on track.